Vaxess Announces Interim Results from Phase I ClinicalTrial of MIMIX-Flu Vaccine Patch

Company focused on creating shot-free future of vaccines and expanding vaccine access; first human trial of Vaxess patch-based influenza vaccine showed strong safety and immunogenicity profiles

InSysBio to release Immune Response Template for QSP modeling in Oncology

InSysBio launches the Oncology version of Immune Response Template (IRT). IRT in Oncology represents a QSP platform of immune system in cancer, simultaneously being a tool for development of QSP and mechanistic models related to tumor-specific immune response.

Quartic.ai Addresses Process Development Capacity Constraints with AI-Powered PD Optimization

New innovation delivers optimal product conditions in fewer runs, reducing raw materials costs, and shaving weeks off of Process Development campaigns

Qlucore participates in major EU project to prevent cardiovascular diseases

Qlucore will be participating in a major EU project that is working to improve preventative treatment for patients at risk of cardiovascular diseases, such as heart attacks and strokes.

Three Featured Products Upgraded at Alfa Chemistry: Protection Reagents, Environmental Goods Standards, Porphyrins and Phthalocyanines

On the occasion of Thanksgiving and Christmas, Alfa Chemistry would like to express its sincere gratitude to its global customers. In addition to discounts and exquisite gifts offered to ordering customers, the company also continuously improves its product lines. Fairly recently, Alfa Chemistry announced the upgrade of its featured products, i.e., protection reagents, environmental goods standards, as well as porphyrins and phthalocyanines, supporting better user experience and wider choices for customers across the world.

CD Formulation Launches One-stop OEM/ODM and Analytical Testing Solutions for Cosmetics

The past decade has seen exponential growth of the cosmeceutical market in the personal care industry. There is increasing use of alpha hydroxy acids for skin rejuvenation as well as the use of vitamin C in topical formulations as an antioxidant. In response to such a trend, CD Formulation recently launched one-stop OEM/ODM and analytical testing solutions for cosmetic formulations.

Curebase Releases Diagnostic Offering that Delivers First All-Inclusive Package of Software and Services Needed to Fully Execute Diagnostic Studies

Start-up trials achieved in eight to 12 weeks, a fraction of typical timeframe

InsightRX Provides Máxima Medical Center with Precision Dosing Guidance

Large teaching hospital in the Netherlands relies on precision dosing platform for point-of-care decision support and immunology research

Triad HealthCare Network Harnesses Medication Data to Improve Outcomes for High-Risk Patients

DrFirst’s MedHx PRM Provides Quick Access to Prescription Fill Information So Healthcare Providers Can Intervene Early to Prevent Readmissions and Optimize Outcomes

CluePoints Appoints Andy Cooper as New Chief Executive Officer

CluePoints Appoints Andy Cooper as New Chief Executive Officer New CEO brings a combination of experience and drive as CluePoints rapidly scales its RBQM and Data Quality Oversight offerings

Inizio acquires Evolution Road, bolstering Evoke’s digital innovation and omnichannel offering

Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery

Leading CRDMO implements market-leading platform to streamline its biotherapeutics discovery workflow and data exchange with biopharma customers

MultiCare Partners with IllumiCare to Offer Clinical Trials at Point-of-Care with Trials App

MultiCare Health System is the first to use the Illumicare Trials App in a clinical setting, streamlining clinical trial recruitment and increasing awareness among providers, patients and clinical research teams.

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury - Company in preparation for formal FDA approval submission

New Draper Study Showcases Powerful New Way to Evaluate Kidney Toxicity

A new study by scientists at Draper adds to the toolbox researchers can use in understanding the biological processes underway in organ-chips. They discovered a new indicator of toxicity in kidney-chips.

ScyTek announces a new special stain kit, The Martius Scarlet Blue (MSB) Stain Kit.

Scytek Laboratories Inc - The Martius Scarlet Blue (MSB) stain kit is intended for use in the histological demonstration of fibrin, muscle, collagen, and erythrocytes. MSB is a reliable method of differentiating fresh and old fibrin clusters.

CATALOG Achieves Historic DNA Computing Milestone

Endor Labs Unveils New Research on Impact of Open Source Software on Supply Chain Security

Endor Labs—a startup taking on the issue of unsecured open source sprawl for healthcare institutions and organizations of every kind – released new research exploring the impact of open source software on supply chain security.

Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence of ENPP1 Deficiency

Leading disease experts and Genomenon published an article titled “Estimation of ENPP1 Deficiency Genetic Prevalence Using a Comprehensive Literature Review and Population Databases” in the Orphanet Journal of Rare Diseases